Physician

Lori S. Whitley, MD

According to 2025 Medicare claims, Lori Whitley, MD (NPI: 1023054913) practices dermatology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is DERMATOLOGY PARTNERS OF NORTHERN NEW MEXICO (NPI: 1245752005; TIN: 82-0805144) and primary practice location at 87505-4752.

Whitley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 823 traditional Medicare patients, billed 4,062 HCPCS/CPT codes, and received $145,559 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 334 prescription claims across 99 beneficiaries totaling $175,149 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 4 records totaling $95. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $84,630 and ending at $175,149. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$85K$170K2015 Medicare payment: $102,016 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $119,153 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $130,443 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $126,994 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $149,530 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $144,261 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $169,763 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $155,590 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $146,997 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $145,559 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156313,293$102,016
20167733,752$119,153
20177983,918$130,443
20188203,735$126,994
20198354,060$149,530
20207983,853$144,261
20218174,464$169,763
20228044,745$155,590
20237724,342$146,997
20248234,062$145,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$150K$299K2015 Drug cost: $84,630 (USD; Tot_Drug_Cst)2016 Drug cost: $65,287 (USD; Tot_Drug_Cst)2017 Drug cost: $178,230 (USD; Tot_Drug_Cst)2018 Drug cost: $299,443 (USD; Tot_Drug_Cst)2019 Drug cost: $206,531 (USD; Tot_Drug_Cst)2020 Drug cost: $141,900 (USD; Tot_Drug_Cst)2021 Drug cost: $141,488 (USD; Tot_Drug_Cst)2022 Drug cost: $125,218 (USD; Tot_Drug_Cst)2023 Drug cost: $106,069 (USD; Tot_Drug_Cst)2024 Drug cost: $175,149 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015117356$84,630
2016114279$65,287
2017104276$178,230
2018124329$299,443
2019126355$206,531
2020124313$141,900
2021124348$141,488
202296285$125,218
202395249$106,069
202499334$175,149

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths232269$72
11102Biopsy of related skin growth, first growth182210$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more656836$55
17000Destruction of precancer skin growth, 1 growth473605$36
17003Destruction of precancer skin growth, 2-14 growths3241,631$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab14392$103,597
PimecrolimusPimecrolimus11330$2,181
CalcipotrieneCalcipotriene14470$1,891
NystatinNystatin24568$1,210
Doxycycline HyclateDoxycycline Hyclate241,450$993

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$95Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lori S. Whitley, MD?

Tedicare shows public-source Medicare data for Lori S. Whitley, MD (NPI 1023054913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lori S. Whitley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lori S. Whitley, MD?

Lori S. Whitley, MD is linked to DERMATOLOGY PARTNERS OF NORTHERN NEW MEXICO (billing NPI 1245752005) in the available physician profile data.

Does Lori S. Whitley, MD have Open Payments data?

Lori S. Whitley, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.